Surgical Margin — Tissue Edge Around a Removed Tumour

In cancer surgery, the surgeon deliberately removes the primary tumour together with an envelope of surrounding healthy tissue. This peripheral rim represents the surgical margin. After resection, the specimen is sent to a pathology laboratory where technicians paint the outer surfaces with special coloured inks to maintain orientation.

The pathologist then cuts thin cross-sections of the specimen and examines them microscopically. The relationship of the tumour cells to the inked border dictates the margin status. If no malignant cells contact the ink, the margin is described as negative or "clear". If cancer cells extend directly to the inked edge, the margin is positive, suggesting microscopic tumour deposits may persist within the surgical bed.

Achieving clear surgical margins is one of the most critical determinants of successful local cancer control and long-term remission. A negative margin significantly decreases the likelihood of cancer returning in the original location (local recurrence). Conversely, a positive or close margin may necessitate an additional operation—known as re-excision—to clear residual disease. In situations where further surgery is impractical or anatomically unsafe, a positive margin signals to the multidisciplinary clinical team that postoperative adjuvant treatments, such as radiotherapy or chemotherapy, are vital to eliminate residual microscopic malignant cells and safeguard patient health.

Surgical margins are evaluated through histological examination by a pathologist. Tissue specimens are inked, fixed in formalin, embedded in paraffin wax, sliced into microscopic sections, and stained with haematoxylin and eosin (H&E). Intraoperatively, surgeons may request frozen section analysis to obtain rapid preliminary feedback on margin status while the patient is still on the operating table, allowing immediate extra tissue clearance if necessary.

Surgical margins are evaluated across almost all solid malignancies treated by surgical excision. They are of paramount importance in breast-conserving surgery (lumpectomy) for breast cancer, where clear boundaries prevent mastectomy. Margins are equally critical in cutaneous malignancies such as malignant melanoma and squamous cell carcinoma, soft tissue sarcomas, and head and neck tumours. Pathologists also systematically evaluate margins in gastrointestinal resections for colorectal, gastric, and pancreatic cancers, as well as pulmonary resections for early-stage lung cancer.

Margin status dictates whether immediate or delayed surgical re-excision is warranted. When negative margins are confirmed with an adequate safety distance, patients may avoid additional operations. If margins are positive or close, options include re-excision of the surgical cavity, wider scar revision, or completion mastectomy in breast cancer. If secondary surgery is not feasible, the oncology team often recommends escalated adjuvant radiotherapy or systemic chemotherapy to sterilise microscopic residual disease.